XML 43 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Valuation (Tables)
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Schedule Of Financial Instruments
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at June 30, 2016:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
50,000

 
$

 
$

 
$
50,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
990,828

 
$
20,506

 
$
1,011,334

U.S. Treasury securities
 

 
374

 

 
374

Private label residential mortgage-backed securities
 

 
78,831

 
112,511

 
191,342

Private label commercial mortgage-backed securities
 

 

 
34,942

 
34,942

Commercial mortgage loans
 

 

 
49,466

 
49,466

Residential mortgage loans
 

 

 
46,649

 
46,649

Collateralized loan obligations
 

 

 
33,109

 
33,109

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
154,395

 
154,395

Corporate debt
 

 

 
36,974

 
36,974

Real estate owned
 

 

 
4,162

 
4,162

Private corporate equity investments
 

 

 
19,418

 
19,418

Total investments, at fair value
 

 
1,070,033

 
512,132

 
1,582,165

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
6,068

 
6,068

Credit default swaps on corporate bond indices
 

 
104,911

 

 
104,911

Credit default swaps on corporate bonds
 

 
583

 

 
583

Credit default swaps on asset-backed indices
 

 
24,616

 

 
24,616

Interest rate swaps
 

 
13,931

 

 
13,931

Total return swaps
 

 

 
824

 
824

Options
 

 
1

 

 
1

Forwards
 

 
1,578

 

 
1,578

Futures
 
8

 

 

 
8

Warrants
 

 

 
100

 
100

Mortgage loan purchase commitments
 

 
8

 

 
8

Total financial derivatives–assets, at fair value
 
8

 
145,628

 
6,992

 
152,628

Repurchase agreements
 

 
116,003

 

 
116,003

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
8

 
$
1,331,664

 
$
519,124

 
$
1,850,796

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(488,151
)
 
$

 
$
(488,151
)
Government debt
 

 
(87,326
)
 

 
(87,326
)
Corporate debt
 

 

 
(9,947
)
 
(9,947
)
Common stock
 
(30,913
)
 

 

 
(30,913
)
Total investments sold short, at fair value
 
(30,913
)
 
(575,477
)
 
(9,947
)
 
(616,337
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(39,797
)
 

 
(39,797
)
Credit default swaps on corporate bonds
 

 
(3,722
)
 

 
(3,722
)
Credit default swaps on asset-backed indices
 

 
(5,868
)
 

 
(5,868
)
Credit default swaps on asset-backed securities
 

 

 
(234
)
 
(234
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Interest rate swaps
 
$

 
$
(22,858
)
 
$

 
$
(22,858
)
Total return swaps
 

 
(2
)
 
(1,016
)
 
(1,018
)
Options
 

 
(243
)
 

 
(243
)
Futures
 
(358
)
 

 

 
(358
)
Total financial derivatives–liabilities, at fair value
 
(358
)
 
(72,490
)
 
(1,250
)
 
(74,098
)
Guarantees(1)
 

 

 
(312
)
 
(312
)
Total investments sold short, financial derivatives–liabilities, and guarantees, at fair value
 
$
(31,271
)
 
$
(647,967
)
 
$
(11,509
)
 
$
(690,747
)

(1)
Included in Other liabilities on the Consolidated Statement of Assets, Liabilities, and Equity.
There were no transfers of financial instruments between Level 1 and Level 2 during the six month period ended June 30, 2016.
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2015:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
160,000

 
$

 
$

 
$
160,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,035,662

 
$
24,918

 
$
1,060,580

Private label residential mortgage-backed securities
 

 
138,482

 
116,435

 
254,917

Private label commercial mortgage-backed securities
 

 

 
34,145

 
34,145

Commercial mortgage loans
 

 

 
66,399

 
66,399

Residential mortgage loans
 

 

 
22,089

 
22,089

Collateralized loan obligations
 

 

 
45,974

 
45,974

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
115,376

 
115,376

Corporate debt
 

 

 
27,028

 
27,028

Real estate owned
 

 

 
12,522

 
12,522

Private corporate equity investments
 

 

 
22,088

 
22,088

Total investments, at fair value
 

 
1,174,144

 
486,974

 
1,661,118

 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 
$

 
$

 
$
6,332

 
$
6,332

Credit default swaps on corporate bond indices
 

 
137,643

 

 
137,643

Credit default swaps on corporate bonds
 

 
10

 

 
10

Credit default swaps on asset-backed indices
 

 
5,410

 

 
5,410

Interest rate swaps
 

 
9,943

 

 
9,943

Total return swaps
 

 

 
85

 
85

Options
 
112

 
2,050

 

 
2,162

Futures
 
32

 

 

 
32

Forwards
 

 
1,138

 

 
1,138

Warrants
 

 

 
150

 
150

Total financial derivatives–assets, at fair value
 
144

 
156,194

 
6,567

 
162,905

Repurchase agreements
 

 
105,700

 

 
105,700

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
144

 
$
1,436,038

 
$
493,541

 
$
1,929,723

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(612,777
)
 
$

 
$
(612,777
)
Government debt
 

 
(114,051
)
 

 
(114,051
)
Corporate debt
 

 

 
(448
)
 
(448
)
Common stock
 
(1,471
)
 

 

 
(1,471
)
Total investments sold short, at fair value
 
(1,471
)
 
(726,828
)
 
(448
)
 
(728,747
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(47,298
)
 

 
(47,298
)
Credit default swaps on corporate bonds
 

 
(683
)
 

 
(683
)
Credit default swaps on asset-backed indices
 

 
(365
)
 

 
(365
)
Credit default swaps on asset-backed securities
 

 

 
(221
)
 
(221
)
Interest rate swaps
 

 
(4,934
)
 

 
(4,934
)
Total return swaps
 

 

 
(4,662
)
 
(4,662
)
Options
 

 
(1,760
)
 

 
(1,760
)
Futures
 
(528
)
 

 

 
(528
)
Forwards
 

 
(13
)
 

 
(13
)
Mortgage loan purchase commitments
 

 
(8
)
 

 
(8
)
Total financial derivatives–liabilities, at fair value
 
(528
)
 
(55,061
)
 
(4,883
)
 
(60,472
)
Guarantees(1)
 

 

 
(828
)
 
(828
)
Total investments sold short, financial derivatives–liabilities, and guarantees, at fair value
 
$
(1,999
)
 
$
(781,889
)
 
$
(6,159
)
 
$
(790,047
)

(1)
Included in Other liabilities on the Consolidated Statement of Assets, Liabilities, and Equity.
There were no transfers of financial instruments between Level 1 and Level 2 during the year ended December 31, 2015.
Schedule Of Significant Unobservable Inputs, Qualitative Information
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of June 30, 2016:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
$
74,172

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
2.03

 
$
181.56

 
$
69.18

Collateralized loan obligations
28,262

 
Market Quotes
 
Non Binding Third-Party Valuation
 
23.00

 
101.75

 
80.78

Corporate debt and non-exchange traded corporate equity
27,576

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.86

 
112.64

 
78.18

Private label commercial mortgage-backed securities
16,454

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.32

 
69.06

 
35.30

Agency interest only residential mortgage-backed securities
16,993

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.72

 
23.01

 
9.83

Total return swaps
(192
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1) 
 
13.61

 
98.00

 
90.45

Private label residential mortgage-backed securities
38,339

 
Discounted Cash Flows
 
Yield
 
3.1
%
 
14.6
%
 
10.9
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
74.7
%
 
12.3
%
 
 
 
 
 
Projected Collateral Losses
 
1.3
%
 
48.7
%
 
34.9
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.0
%
 
53.1
%
 
35.9
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
85.6
%
 
16.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
18,488

 
Discounted Cash Flows
 
Yield
 
11.6
%
 
32.8
%
 
22.9
%
 
 
 
 
 
Projected Collateral Losses
 
0.8
%
 
3.6
%
 
1.8
%
 
 
 
 
 
Projected Collateral Recoveries
 
4.4
%
 
15.0
%
 
7.3
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
83.1
%
 
94.8
%
 
90.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
10,444

 
Discounted Cash Flows
 
Yield
 
0.0
%
 
16.9
%
 
16.3
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Collateralized loan obligations
$
4,847

 
Discounted Cash Flows
 
Yield
 
10.1
%
 
42.3
%
 
17.1
%
 
 
 
 
 
Projected Collateral Prepayments
 
41.0
%
 
62.2
%
 
55.5
%
 
 
 
 
 
Projected Collateral Losses
 
2.6
%
 
12.1
%
 
6.5
%
 
 
 
 
 
Projected Collateral Recoveries
 
1.4
%
 
6.5
%
 
4.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
30.0
%
 
51.4
%
 
34.0
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
154,395

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
25.0
%
 
10.3
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
45.6
%
 
39.1
%
 
 
 
 
 
Projected Collateral Losses
 
0.9
%
 
96.9
%
 
7.9
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
83.9
%
 
53.0
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
25,795

 
Discounted Cash Flows
 
Yield
 
10.4
%
 
17.9
%
 
11.8
%
Non-performing commercial mortgage loans
23,671

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
18.4
%
 
14.2
%
 
 
 
 
 
Months to Resolution
 
6.0

 
39.0

 
20.8

Performing residential mortgage loans
41,324

 
Discounted Cash Flows
 
Yield
 
5.0
%
 
13.1
%
 
6.5
%
Non-performing residential mortgage loans and residential real estate owned
7,646

 
Discounted Cash Flows
 
Yield
 
5.7
%
 
60.6
%
 
10.4
%
 
 
 
 
 
Months to Resolution
 
1.9

 
112.9

 
25.9

Credit default swaps on asset-backed securities
5,834

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
27.4
%
 
40.2
%
 
34.0
%
 
 
 
 
 
Projected Collateral Losses
 
17.7
%
 
33.2
%
 
26.6
%
 
 
 
 
 
Projected Collateral Recoveries
 
7.1
%
 
14.1
%
 
10.8
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
23.4
%
 
32.2
%
 
28.6
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded equity investments in commercial mortgage-related private partnerships
2,972

 
Discounted Cash Flows
 
Yield
 
16.5
%
 
16.5
%
 
16.5
%
 
 
 
 
 
Expected Holding Period (Months)
 
8.7

 
8.7

 
8.7

Agency interest only residential mortgage-backed securities
3,513

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
118

 
1,818

 
468

 
 
 
 
 
Projected Collateral Prepayments
 
20.4
%
 
100.0
%
 
69.6
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
79.6
%
 
30.4
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entities
3,053

 
Enterprise Value
 
Equity Multiple(3)
 
2.3x
 
2.3x
 
2.3x
Commercial real estate owned
1,841

 
Recent Transactions
 
Contract Price
 
96.77
 
96.77
 
96.77
Non-exchange traded preferred and common equity investment in mortgage-related entities
2,500

 
Recent Transactions
 
Transaction Price
 
N/A
 
N/A
 
N/A
Guarantees
(312
)
 
Cash Flows
 
Expected Cash Flows(4)
 
N/A
 
N/A
 
N/A
(1)
Represents valuations on underlying assets.
(2)
Shown in basis points.
(3)
Represent an estimation of where market participants might value an enterprise.
(4)
Represents transactions with a remaining term of less than one year.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2015:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
$
89,549

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
1.81

 
$
151.86

 
$
68.47

Collateralized loan obligations
41,978

 
Market Quotes
 
Non Binding Third-Party Valuation
 
13.00

 
102.00

 
84.84

Corporate debt and non-exchange traded corporate equity
18,972

 
Market Quotes
 
Non Binding Third-Party Valuation
 
3.00

 
200.00

 
77.85

Private label commercial mortgage-backed securities
20,365

 
Market Quotes
 
Non Binding Third-Party Valuation
 
6.07

 
73.20

 
41.28

Agency interest only residential mortgage-backed securities
21,067

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.97

 
22.41

 
11.08

Total return swaps
(4,577
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1)
 
36.38

 
99.88

 
56.38

Private label residential mortgage-backed securities
26,886

 
Discounted Cash Flows
 
Yield
 
3.4
%
 
27.1
%
 
19.9
%
 
 
 
 
 
Projected Collateral Prepayments
 
5.4
%
 
74.6
%
 
46.3
%
 
 
 
 
 
Projected Collateral Losses
 
2.9
%
 
24.5
%
 
11.4
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
13.0
%
 
8.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
8.6
%
 
88.6
%
 
34.3
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
13,780

 
Discounted Cash Flows
 
Yield
 
19.2
%
 
25.0
%
 
22.1
%
 
 
 
 
 
Projected Collateral Losses
 
0.7
%
 
2.3
%
 
1.6
%
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
14.3
%
 
8.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
83.4
%
 
97.6
%
 
90.0
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
13,920

 
Discounted Cash Flows
 
Yield
 
15.0
%
 
20.0
%
 
16.2
%
Collateralized loan obligations
3,996

 
Discounted Cash Flows
 
Yield
 
8.3
%
 
20.6
%
 
13.5
%
 
 
 
 
 
Projected Collateral Prepayments
 
31.9
%
 
52.3
%
 
41.1
%
 
 
 
 
 
Projected Collateral Losses
 
2.6
%
 
17.3
%
 
12.9
%
 
 
 
 
 
Projected Collateral Recoveries
 
2.3
%
 
15.5
%
 
10.1
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
33.3
%
 
51.5
%
 
35.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans(2)
115,376

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
15.0
%
 
10.4
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
40.9
%
 
30.9
%
 
 
 
 
 
Projected Collateral Losses
 
1.0
%
 
33.8
%
 
7.3
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
57.3
%
 
80.8
%
 
61.8
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
43,847

 
Discounted Cash Flows
 
Yield
 
9.8
%
 
17.6
%
 
11.9
%
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Non-performing commercial mortgage loans and commercial real estate owned
$
30,984

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
19.4
%
 
13.7
%
 
 
 
 
 
Months to Resolution
 
4.0

 
24.0

 
9.3

Performing residential mortgage loans
13,848

 
Discounted Cash Flows
 
Yield
 
5.5
%
 
8.0
%
 
6.5
%
Non-performing residential mortgage loans and residential real estate owned
12,331

 
Discounted Cash Flows
 
Yield
 
5.7
%
 
7.9
%
 
7.3
%
 
 
 
 
 
Months to Resolution
 
3.4

 
113.6

 
20.6

Credit default swaps on asset-backed securities
6,111

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
26.6
%
 
44.1
%
 
32.6
%
 
 
 
 
 
Projected Collateral Losses
 
15.0
%
 
33.7
%
 
26.5
%
 
 
 
 
 
Projected Collateral Recoveries
 
6.8
%
 
16.9
%
 
12.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
24.5
%
 
33.1
%
 
28.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred equity investment in commercial mortgage-related private partnership
10,558

 
Discounted Cash Flows
 
Yield
 
14.0
%
 
16.5
%
 
14.7
%
 
 
 
 
 
Expected Holding Period (Months)
 
14.3

 
27.0

 
23.5

Agency interest only residential mortgage-backed securities
3,851

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
441

 
1,672

 
622

 
 
 
 
 
Projected Collateral Prepayments
 
18.0
%
 
100.0
%
 
70.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
82.0
%
 
29.6
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entities
2,738

 
Enterprise Value
 
Equity Multiple(3)
 
2.7x

 
2.7x

 
2.7x

Non-exchange traded preferred and common equity investment in mortgage-related entities
2,630

 
Recent Transactions
 
Transaction Price
 
N/A

 
N/A

 
N/A

Guarantees
(828
)
 
Cash Flows
 
Expected Cash Flows(4)
 
N/A

 
N/A

 
N/A

(1)
Represents valuations on underlying assets.
(2)
Shown in basis points.
(3)
Represent an estimation of where market participants might value an enterprise.
(4)
Represents transactions with a remaining term of less than one year.
Fair Value Measurement Using Significant Unobservable Inputs
The tables below include a roll-forward of the Company's financial instruments for the three and six month periods ended June 30, 2016 and 2015 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended June 30, 2016
(In thousands)
Ending
Balance as of 
March 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
22,306

 
$
(1,888
)
 
$
(82
)
 
$
(133
)
 
$
303

 
$

 
$

 
$

 
$
20,506

Private label residential mortgage-backed securities
113,382

 
1,109

 
(290
)
 
(1,310
)
 
1,687

 
(6,100
)
 
12,823

 
(8,790
)
 
112,511

Private label commercial mortgage-backed securities
35,350

 
431

 

 
(839
)
 

 

 

 

 
34,942

Commercial mortgage loans
56,365

 
727

 
(1
)
 
(671
)
 

 
(6,954
)
 

 

 
49,466

Residential mortgage loans
35,580

 
141

 
757

 
(147
)
 
17,101

 
(6,783
)
 

 

 
46,649

Collateralized loan obligations
34,415

 
(1,942
)
 
(279
)
 
145

 
1,178

 
(408
)
 

 

 
33,109

Consumer loans and asset-backed securities backed by consumer loans
143,854

 
(2,713
)
 
6

 
(655
)
 
37,046

 
(23,143
)
 

 

 
154,395

Corporate debt
24,552

 
(160
)
 
275

 
1,874

 
49,353

 
(38,920
)
 

 

 
36,974

Real estate owned
21,843

 

 
1,978

 
(1,750
)
 
884

 
(18,793
)
 

 

 
4,162

Private corporate equity investments
24,599

 

 
101

 
697

 
2,590

 
(8,569
)
 

 

 
19,418

Total investments, at fair value
512,246

 
(4,295
)
 
2,465

 
(2,789
)
 
110,142

 
(109,670
)
 
12,823

 
(8,790
)
 
512,132

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
6,227

 

 
373

 
(149
)
 
(24
)
 
(359
)
 

 

 
6,068

Total return swaps
1,074

 

 
3,412

 
(250
)
 
(3,146
)
 
(266
)
 

 

 
824

Warrants
100

 

 

 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
7,401

 

 
3,785

 
(399
)
 
(3,170
)
 
(625
)
 

 

 
6,992

Total investments and financial derivatives–assets, at fair value
$
519,647

 
$
(4,295
)
 
$
6,250

 
$
(3,188
)
 
$
106,972

 
$
(110,295
)
 
$
12,823

 
$
(8,790
)
 
$
519,124

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(3,029
)
 
$
(9
)
 
$
171

 
$
(309
)
 
$
10,368

 
$
(17,139
)
 
$

 
$

 
$
(9,947
)
Total investments sold short, at fair value
(3,029
)
 
(9
)
 
171

 
(309
)
 
10,368

 
(17,139
)
 

 

 
(9,947
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
March 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2016
(continued)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(220
)
 
$

 
$
(63
)
 
$
24

 
$

 
$
25

 
$

 
$

 
$
(234
)
Total return swaps
(675
)
 

 
(2,115
)
 
(342
)
 
2,348

 
(232
)
 

 

 
(1,016
)
Total financial derivatives– liabilities, at fair value
(895
)
 

 
(2,178
)
 
(318
)
 
2,348

 
(207
)
 

 

 
(1,250
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(616
)
 

 

 
304

 

 

 

 

 
(312
)
Total guarantees
(616
)
 

 

 
304

 

 

 

 

 
(312
)
Total investments sold short, financial derivatives– liabilities, and guarantees, at fair value
$
(4,540
)
 
$
(9
)
 
$
(2,007
)
 
$
(323
)
 
$
12,716

 
$
(17,346
)
 
$

 
$

 
$
(11,509
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the three month period ended June 30, 2016. For Level 3 financial instruments held by the Company at June 30, 2016, change in net unrealized gain (loss) of $(2.2) million, $(0.03) million, $0.3 million, $(0.6) million, and $0.3 million, for the three month period ended June 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
As of June 30, 2016, the Company transferred $8.8 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, as of June 30, 2016, the Company transferred $12.8 million of non-Agency RMBS from Level 2 to Level 3. Since March 31, 2016, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Three Month Period Ended June 30, 2015
(In thousands)
Ending
Balance as of 
March 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2015
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
26,335

 
$
(1,941
)
 
$

 
$
1,604

 
$
6,317

 
$
(1,930
)
 
$

 
$

 
$
30,385

Private label residential mortgage-backed securities
169,371

 
1,824

 
4,423

 
(40
)
 
40,761

 
(55,420
)
 
20,165

 
(21,038
)
 
160,046

Private label commercial mortgage-backed securities
52,214

 
556

 
(91
)
 
(792
)
 
4,538

 
(6,591
)
 

 

 
49,834

Commercial mortgage loans
38,918

 
736

 

 
(637
)
 
26,519

 
(10,226
)
 

 

 
55,310

Residential mortgage loans
30,845

 
405

 
1,422

 
(215
)
 
3,782

 
(15,310
)
 

 

 
20,929

Collateralized loan obligations
88,847

 
149

 
(819
)
 
252

 
39,110

 
(29,151
)
 

 

 
98,388

Consumer loans and asset-backed securities backed by consumer loans
34,773

 
(1,701
)
 

 
225

 
25,082

 
(5,922
)
 

 

 
52,457

Corporate debt
31,836

 
16

 
(78
)
 
(1,809
)
 
1,025

 
(4,712
)
 

 

 
26,278

Real estate owned
9,070

 

 
164

 
(10
)
 
2,774

 
(2,496
)
 

 

 
9,502

Private corporate equity investments
21,300

 

 
115

 
268

 
1,116

 
(450
)
 

 

 
22,349

Total investments, at fair value
503,509

 
44

 
5,136

 
(1,154
)
 
151,024

 
(132,208
)
 
20,165

 
(21,038
)
 
525,478

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
10,809

 

 
(1,563
)
 
1,056

 
3

 
(856
)
 

 

 
9,449

Total return swaps
118

 

 
285

 
130

 
21

 
(307
)
 

 

 
247

Warrants
100

 

 

 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
11,027

 

 
(1,278
)
 
1,186

 
24

 
(1,163
)
 

 

 
9,796

Total investments and financial derivatives–assets, at fair value
$
514,536

 
$
44

 
$
3,858

 
$
32

 
$
151,048

 
$
(133,371
)
 
$
20,165

 
$
(21,038
)
 
$
535,274

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(239
)
 
$

 
$
(23
)
 
$
(41
)
 
$

 
$
23

 
$

 
$

 
$
(280
)
Total return swaps
(307
)
 

 
353

 
(1,596
)
 
(353
)
 

 

 

 
(1,903
)
Total financial derivatives– liabilities, at fair value
(546
)
 

 
330

 
(1,637
)
 
(353
)
 
23

 

 

 
(2,183
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(669
)
 

 

 
1

 
13

 

 

 

 
(655
)
Total securitized debt
(669
)
 

 

 
1

 
13

 

 

 

 
(655
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,215
)
 
$

 
$
330

 
$
(1,636
)
 
$
(340
)
 
$
23

 
$

 
$

 
$
(2,838
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2015, as well as Level 3 financial instruments disposed of by the Company during the three month period ended June 30, 2015. For Level 3 financial instruments held by the Company at June 30, 2015, change in net unrealized gain (loss) of $(0.6) million, $1.2 million, $(1.7) million, and $1 thousand, for the three month period ended June 30, 2015 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and securitized debt, respectively.
As of June 30, 2015, the Company transferred $21.0 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, as of June 30, 2015, the Company transferred $20.2 million of non-Agency RMBS from Level 2 to Level 3. These securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Six Month Period Ended June 30, 2016
(In thousands)
Ending
Balance as of 
December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
24,918

 
$
(3,945
)
 
$
(90
)
 
$
(679
)
 
$
302

 
$

 
$

 
$

 
$
20,506

Private label residential mortgage-backed securities
116,435

 
1,517

 
(283
)
 
(2,370
)
 
7,419

 
(12,461
)
 
11,261

 
(9,007
)
 
112,511

Private label commercial mortgage-backed securities
34,145

 
886

 
322

 
(3,840
)
 
7,844

 
(4,415
)
 

 

 
34,942

Commercial mortgage loans
66,399

 
1,272

 
182

 
223

 
13,424

 
(32,034
)
 

 

 
49,466

Residential mortgage loans
22,089

 
248

 
865

 
127

 
32,066

 
(8,746
)
 

 

 
46,649

Collateralized loan obligations
45,974

 
(2,869
)
 
801

 
417

 
1,178

 
(12,392
)
 

 

 
33,109

Consumer loans and asset-backed securities backed by consumer loans
115,376

 
(5,596
)
 
6

 
(549
)
 
88,956

 
(43,798
)
 

 

 
154,395

Corporate debt
27,028

 
(46
)
 
255

 
(2,102
)
 
52,320

 
(40,481
)
 

 

 
36,974

Real estate owned
12,522

 

 
2,238

 
(331
)
 
10,672

 
(20,939
)
 

 

 
4,162

Private corporate equity investments
22,088

 

 
(29
)
 
(531
)
 
6,517

 
(8,627
)
 

 

 
19,418

Total investments, at fair value
486,974

 
(8,533
)
 
4,267

 
(9,635
)
 
220,698

 
(183,893
)
 
11,261

 
(9,007
)
 
512,132

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
6,332

 

 
464

 
(255
)
 
12

 
(485
)
 

 

 
6,068

Total return swaps
85

 

 
(103
)
 
739

 
423

 
(320
)
 

 

 
824

Warrants
150

 

 
(50
)
 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
6,567

 

 
311

 
484

 
435

 
(805
)
 

 

 
6,992

Total investments and financial derivatives–assets, at fair value
$
493,541

 
$
(8,533
)
 
$
4,578

 
$
(9,151
)
 
$
221,133

 
$
(184,698
)
 
$
11,261

 
$
(9,007
)
 
$
519,124

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(448
)
 
$
(8
)
 
$
531

 
$
(558
)
 
$
11,255

 
$
(20,719
)
 
$

 
$

 
$
(9,947
)
Total investments sold short, at fair value
(448
)
 
(8
)
 
531

 
(558
)
 
11,255

 
(20,719
)
 

 

 
(9,947
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2016
(continued)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(221
)
 
$

 
$
(79
)
 
$
24

 
$

 
$
42

 
$

 
$

 
$
(234
)
Total return swaps
(4,662
)
 

 
(4,365
)
 
3,646

 
4,686

 
(321
)
 

 

 
(1,016
)
Total financial derivatives– liabilities, at fair value
(4,883
)
 

 
(4,444
)
 
3,670

 
4,686

 
(279
)
 

 

 
(1,250
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(828
)
 

 

 
516

 

 

 

 

 
(312
)
Total guarantees
(828
)
 

 

 
516

 

 

 

 

 
(312
)
Total investments sold short, financial derivatives– liabilities, and guarantees, at fair value
$
(6,159
)
 
$
(8
)
 
$
(3,913
)
 
$
3,628

 
$
15,941

 
$
(20,998
)
 
$

 
$

 
$
(11,509
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the six month period ended June 30, 2016. For Level 3 financial instruments held by the Company at June 30, 2016, change in net unrealized gain (loss) of $(10.9) million, $(0.04) million, $0.9 million, $(0.1) million, and $0.5 million, for the six month period ended June 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
As of June 30, 2016, the Company transferred $9.0 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, as of June 30, 2016, the Company transferred $11.3 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2015, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Six Month Period Ended June 30, 2015
(In thousands)
Ending
Balance as of December 31, 2014
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
June 30, 2015
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
31,385

 
$
(3,947
)
 
$
472

 
$
1,508

 
$
7,506

 
$
(6,539
)
 
$

 
$

 
$
30,385

Private label residential mortgage-backed securities
274,369

 
4,692

 
11,397

 
(3,889
)
 
58,464

 
(113,848
)
 
6,490

 
(77,629
)
 
160,046

Private label commercial mortgage-backed securities
53,311

 
1,928

 
523

 
(2,692
)
 
20,132

 
(23,368
)
 

 

 
49,834

Commercial mortgage loans
28,309

 
1,275

 

 
(620
)
 
50,810

 
(24,464
)
 

 

 
55,310

Residential mortgage loans
27,482

 
848

 
1,664

 
(70
)
 
9,758

 
(18,753
)
 

 

 
20,929

Collateralized loan obligations
123,338

 
(4,473
)
 
(48
)
 
(1,453
)
 
49,587

 
(68,563
)
 

 

 
98,388

Consumer loans and asset-backed securities backed by consumer loans
22,950

 
(3,419
)
 

 
776

 
41,139

 
(8,989
)
 

 

 
52,457

Corporate debt
42,708

 
47

 
108

 
(2,390
)
 
12,630

 
(26,825
)
 

 

 
26,278

Real estate owned
8,635

 

 
248

 
527

 
5,245

 
(5,153
)
 

 

 
9,502

Private corporate equity investments
14,512

 

 
116

 
498

 
7,688

 
(465
)
 

 

 
22,349

Total investments, at fair value
626,999

 
(3,049
)
 
14,480

 
(7,805
)
 
262,959

 
(296,967
)
 
6,490

 
(77,629
)
 
525,478

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
11,387

 
$

 
$
(1,162
)
 
$
701

 
$
25

 
$
(1,502
)
 
$

 
$

 
$
9,449

Total return swaps

 

 
285

 
248

 
21

 
(307
)
 

 

 
247

Warrants
100

 

 

 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
11,487

 

 
(877
)
 
949

 
46

 
(1,809
)
 

 

 
9,796

Total investments and financial derivatives–assets, at fair value
$
638,486

 
$
(3,049
)
 
$
13,603

 
$
(6,856
)
 
$
263,005

 
$
(298,776
)
 
$
6,490

 
$
(77,629
)
 
$
535,274

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(239
)
 
$

 
$
(42
)
 
$
(41
)
 
$

 
$
42

 
$

 
$

 
$
(280
)
Total return swaps

 

 
353

 
(1,903
)
 
(353
)
 

 

 

 
(1,903
)
Total financial derivatives– liabilities, at fair value
(239
)
 

 
311

 
(1,944
)
 
(353
)
 
42

 

 

 
(2,183
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(774
)
 
(2
)
 

 
20

 
101

 

 

 

 
(655
)
Total securitized debt
(774
)
 
(2
)
 

 
20

 
101

 

 

 

 
(655
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,013
)
 
$
(2
)
 
$
311

 
$
(1,924
)
 
$
(252
)
 
$
42

 
$

 
$

 
$
(2,838
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2015, as well as Level 3 financial instruments disposed of by the Company during the six month period ended June 30, 2015. For Level 3 financial instruments held by the Company at June 30, 2015, change in net unrealized gain (loss) of $(1.0) million, $1.0 million, $(1.9) million, and $0.02 million for the six month period ended June 30, 2015 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and securitized debt, respectively.
As of June 30, 2015, the Company transferred $77.6 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, as of June 30, 2015, the Company transferred $6.5 million of non-Agency RMBS from Level 2 to Level 3. Following December 2014, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.